Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
How One Doctor Navigated Orthopedic Residency While Pregnant
Dr. Cristina DelPrete entered an orthopaedic surgery residency three months pregnant and completed six months of demanding clinical duties without missing any educational obligations. Her program adjusted her schedule during the final weeks of pregnancy, and she returned after a six‑week ACGME‑approved leave, continuing to excel. The Ruth Jackson Orthopaedic Society honored her with the Dr. Jessi Block Courage Award, spotlighting her perseverance amid a specialty where women comprise only 7‑8% of practicing surgeons. The narrative underscores ongoing gender‑equity challenges in orthopaedics.
Spain Plants US$200m Flag in Boston with Debut US Biotech Fund
Spain has unveiled a $200 million venture‑capital fund based in Boston, anchored by $57 million of public seed capital. The fund will back Spanish life‑science startups seeking to scale within the U.S. ecosystem and co‑invest in select American biotech firms. A new...
Childhood Vaccine Schedule: Court Ruling Raises Questions About Who Decides
The episode examines a recent federal court ruling that upheld the American Academy of Pediatrics' (AAP) authority over the childhood vaccine schedule, blocking attempts to scale it back. Guest Dr. Ryan Cole, head of medical and scientific affairs at the Independent...
British Columbia Leads By Example, Passing Law That Mandates Creation Of Health Screenings For Wildland Firefighters.
British Columbia has enacted the Firefighters’ Health Act, obligating the provincial government to develop and maintain a province‑wide health‑screening program for wildland firefighters. The legislation also requires a review of occupational disease presumptions, targeting cancer and mental‑health conditions linked to...
Medicare Already Funds Universal Care, Not Insurers
Your “who’s gonna pay for universal healthcare” gotcha isn’t actually a gotcha. Here’s why from AOC. — We’ve paid for universal Medicare twice over. We’re just giving all the money to for-profit health insurers like United Healthcare. In exchange we all...
Senior Midwife Appointed to Maternity Inquiry
The UK Health Secretary Wes Streeting has appointed senior midwife Donna Ockenden to head an independent inquiry into maternity services at University Hospitals Sussex NHS Trust. The review follows a series of bereavement and harm cases, including the 2021 death...
Fujifilm Biotechnologies Opens New QC Lab in Denmark
Fujifilm Biotechnologies has opened a 2,000‑square‑meter GMP‑approved quality control laboratory at its Hillerød, Denmark site. The facility, designed for bioassay and virology work, will accommodate roughly 100 quality‑team members and features robotics, airlocks and a new LIMS for digital data...
Monkeys Walk Around a Virtual World Using only Their Thoughts
Researchers at KU Leuven implanted three rhesus macaques with 288 micro‑electrodes across primary motor, dorsal premotor and ventral premotor cortices. An AI model decoded the neural activity, allowing the monkeys to steer avatars through a series of 3D virtual environments...
Hawke’s Bay First Prostate LDR Brachytherapy Patient Back on Motorbike Within Weeks
In February 2026, Nick Mardle became Hawke’s Bay’s first patient to receive low‑dose‑rate (LDR) brachytherapy for prostate cancer, a minimally invasive internal radiotherapy previously only offered in Christchurch and Tauranga. The three‑hour outpatient procedure allowed him to resume motorbike riding...
Central Hawke’s Bay Mum Has Leg Removed in Fight Against Clear Cell Sarcoma Pain
Alicia Brough, a Central Hawke’s Bay mother, had her right leg amputated to excise a stage‑four clear cell sarcoma that had metastasized to her lungs and lymph nodes. After a three‑week Keytruda regimen in Mexico caused type 1 diabetes and liver...
Iran War Leads To Fluoride Shortages For Some US Water Utilities
U.S. water utilities in Maryland and Pennsylvania have reduced fluoride levels due to shortages of hydrofluorosilicic acid, a key fluoridation chemical, caused by supply chain disruptions linked to the Israel‑Iran conflict. Baltimore and WSSC Water cut concentrations from the CDC‑recommended...
I Tried Price Shopping for Health Care. It Isn’t Worth It – Not Yet.
The author tried to price‑shop a CT scan after a back injury and discovered that the lowest‑cost, in‑network provider didn’t offer the needed service, forcing a longer trip to a pricier location. The experience highlights how inaccurate provider directories, opaque...
From Call Center to Care Center: How Hospitals Mature in Their Approach to Patient Experience
Hospitals are moving from traditional call centers to integrated care centers to meet rising patient‑experience expectations. Fragmented legacy systems create long wait times, while AI‑driven routing, CRM/EHR integration, and omnichannel tools streamline interactions. The shift delivers measurable ROI by cutting...
Real-World Evoque Data Reassure, but It’s Still Early Days With TTVR
Early US real‑world data from the TVT Registry show that transcatheter tricuspid valve replacement (TTVR) with Edwards' Evoque device matches or modestly exceeds outcomes from the pivotal TRISCEND II trial. In 1,034 patients (average age 77, 69% female) 30‑day mortality was...
QT Imaging, Olea Medical Introduce New Viewer for Integrated, Multimodality Breast Imaging
QT Imaging Holdings and Olea Medical have launched the QTI Imaging‑Olea Viewer, a unified platform that merges QTscan acoustic CT data with mammography, digital breast tomosynthesis, MRI and ultrasound. The viewer delivers 3‑D volumetric imaging without ionizing radiation, targeting dense‑breast...
New Drug Protects Against Life-Threatening Pancreatitis
A new RNA‑based drug, plozasiran, received its first clinical validation for a rare inherited disorder that causes extreme blood‑fat accumulation and recurrent acute pancreatitis. In the PALISADE trial, a single injection every three months lowered the risk of pancreatitis by...
CRISPR Variant Selectively Targets Tumor DNA
Researchers at Van Andel Institute and Wageningen University have engineered a CRISPR variant, ThermoCas9, that reads DNA methylation patterns to differentiate tumor DNA from healthy DNA. The enzyme selectively cuts methylated cancer sequences while sparing unmethylated normal genes, a finding published...
Better Way Conference Speaker Update: Co-Creating New Health Solutions. A Better Way for the USA.
The World Council for Health announced the Better Way Conference will take place in Rhode Island from May 29‑31, 2026. Dr. Paul Marik and Prof. Angus Dalgleish will lead a Cancer Workshop on May 30, while a range of high‑profile health figures are...
"Build Momentum, Build Adoption"
The post argues that momentum—driven by surgeon awareness, interest, and adoption—shapes the orthopedic market. OTW accelerates each stage by showcasing research to the most influential spine surgeons. By publishing through the OTW Spine Research Hub, investigators can spark wider clinical...
National Nurses Week Needs Better Nursing Recognition
National Nurses Week remains a token gesture, often limited to emails, donuts, or branded swag, while modern nursing demands data‑driven decision‑making, systems thinking, and high‑stakes clinical vigilance. The article argues that recognition should reflect this technical expertise, citing Florence Nightingale’s...
HFMA Members Urged to Evaluate and Reply to Prospective New GASB Statement
The Healthcare Financial Management Association (HFMA) is urging its members to review the Governmental Accounting Standards Board’s proposed Statement No. 103, which provides new guidance on classifying and treating subsidies in governmental accounting. The draft guidance, released as an implementation guide,...
Merit Medical Removes Dialysis Catheter Introducer in FDA Class I Recall
Merit Medical announced a Class I FDA recall of its 16F Dual‑Valved Splittable Sheath Introducer, a component used in several dialysis catheter kits. The sheath may fail to split during catheter placement, potentially causing hemorrhage, embolization, thrombosis, or loss of...
FDA Links Weight Loss Pill to ‘Unexpected’ Cardiovascular Risks
Eli Lilly’s oral GLP‑1 weight‑loss pill Foundayo (orforglipron) received FDA approval in early April, becoming the second oral GLP‑1 on the market after Novo Nordisk’s semaglutide. The agency’s approval letter, however, highlighted an unexpected serious risk of major adverse cardiovascular events, along...
Abridge Incorporates More Clinical Evidence Into Its Decision Support Tools
Abridge announced multiyear partnerships with the New England Journal of Medicine and the JAMA Network, adding their peer‑reviewed research to its AI‑driven clinical decision‑support platform. The new content will join existing UpToDate data, allowing the system to surface evidence‑based answers...
Los Angeles Therapist Dr. Sara Spowart Wins Health 2.0 Award for Happiness-Based Mindfulness Model
Los Angeles therapist Dr. Sara Spowart was honored with the Health 2.0 Excellence in Healthcare Award for her Happiness-Based Mindfulness model. The accolade highlights a growing industry focus on sustainable, empathy‑driven mental‑health care.
InSPECt™ MS – Global HCP Profiling and Quantification by Native Digestion and LC-MS Analysis
The inSPECt™ MS platform combines native digestion with high‑resolution LC‑MS to quantify host‑cell proteins (HCPs) relative to spiked‑in protein standards. Calibration using the Cygnus Protein Standard demonstrated a linear response from 10 to 500 ppm with coefficients of variation under 18 %...
Study of 10 Million Siblings Links Birth Order to Autism, Migraines and More
Researchers analyzing health records of more than 10 million siblings discovered that firstborn children are disproportionately likely to be diagnosed with autism and allergies, whereas younger siblings show higher rates of migraine, shingles and other conditions. The findings, published this week,...
Stanford Scientists Unveil AI-Discovered Peptide That Replicates GLP-1 Benefits Without Side Effects
Stanford Medicine researchers have identified a naturally occurring 12‑amino‑acid peptide, BRP, that mimics the appetite‑suppressing effects of semaglutide (Ozempic) while sidestepping common side effects. The discovery, powered by an AI tool called Peptide Predictor, showed weight‑loss and glucose‑control benefits in...
Why Attend the Toronto Life Sciences and Biotech Summit 2026
The Toronto Life Sciences and Biotech Summit on May 7, 2026 will convene real‑estate developers, biotech executives and ecosystem partners to address funding constraints, talent dynamics, and evolving lab‑space demand in the Greater Toronto Area. Speakers will explore how slower...
IDEAYA Biosciences Shows 58% Reduction in Disease Progression in Late‑Stage Uveal Melanoma Trial
IDEAYA Biosciences and Servier announced that their Phase II/III OptimUM‑02 trial of darovasertib combined with crizotinib reduced disease‑progression risk by 58% in first‑line HLA‑A*02:01‑negative metastatic uveal melanoma. The combination achieved a median progression‑free survival of 6.9 months versus 3.1 months...
TOBY Gets FDA Breakthrough Device Designation for Urine-Based Multi-Cancer Test
TOBY, Inc., a Texas biotech firm, earned FDA Breakthrough Device Designation for its urine‑based multi‑cancer early detection (MCED) test. The designation accelerates clinical validation and could reshape non‑invasive cancer screening.
MiniMed Flexes with Next-Gen Insulin Pump After Spinning Off From Medtronic
MiniMed, the newly independent diabetes business spun out of Medtronic, secured FDA clearance for its next‑generation MiniMed Flex insulin pump within two weeks of its March 2026 IPO. The Flex is a screenless, pocket‑sized device that retains the 300‑unit reservoir...
Maricopa County Issues Measles Exposure Alerts for Three Queen Creek Venues
Maricopa County health officials confirmed a measles case and warned that visitors to three Queen Creek sites may have been exposed. The alerts come as Arizona reports 78 cases statewide in 2026, underscoring a resurgence of vaccine‑preventable disease.
Graphene‑Oxide Nanoplatform Merges Proteasome Inhibition and Phototherapy for Oral Cancer
Scientists have introduced a graphene‑oxide‑based nanoplatform that simultaneously delivers proteasome inhibitors and phototherapy to oral cancer cells. Preclinical tests indicate the combined approach outperforms each modality alone, offering a potential route to more precise, less toxic treatment.
Researchers Find DMT Provides Longer-Lasting Antidepressant Effects than S-Ketamine in Animal Models
A recent Neuropharmacology study shows that a single dose of the psychedelic N,N‑dimethyltryptamine (DMT) produces rapid antidepressant effects in mice that last up to eight days, outperforming S‑ketamine’s shorter‑lived impact. Both compounds reversed learned‑helplessness behavior within 24 hours, but only...
Natural Disaster Trauma Requires Mental Health Planning
Super Typhoon Sinlaku highlighted a hidden health crisis: the lingering physiological and psychological stress that persists long after wind speeds drop. While hospitals focus on generators and supply chains, patients often experience sustained hypertension, panic attacks, and substance‑use spikes that are...
IPSC-Based Manufacture Vs. Autologous Model Production Costs Examined via Financial Analysis
A new Cellistic white paper quantifies the cost advantage of using induced pluripotent stem cells (iPSCs) to manufacture NK cell therapies. The analysis shows cost of goods per dose can drop to roughly $5,000, a 95% reduction compared with $115,000...
This Pill May Help Pancreatic Cancer Patients Live Longer
Revolution Medicines announced that its RAS‑blocking pill daraxonrasib more than doubled median overall survival for patients with metastatic pancreatic cancer, extending it to 13.2 months versus 6.7 months on chemotherapy. The data will support an expedited FDA filing, and the...
Doctor Cuts GLP‑1 After Low BMI, Dosage Adjusted
Quick update on the GLP-1s: Doctor told me yesterday to get off it, BMI (19.2) too low. Was always on the lowest dose of Zepbound, so will cut that in half (0.5 x 2.5mg) and space out (7 -> 10 -> 14...
In Vivo Autoimmune CAR-T Race Grows as Two RNA Startups Enter the Clinic
Two RNA‑focused biotech firms have entered human trials of in vivo CAR‑T therapies targeting autoimmune diseases. China’s Immorna reported its first systemic sclerosis patient treated with an RNA‑delivered CAR‑T that reduced peripheral B‑cell activity. A U.S. startup, GeneCure, launched a...
US FDA to Convene Expert Panel to Review Wider Access to some Peptides
The U.S. Food and Drug Administration announced it will convene an external advisory panel in July to decide whether licensed compounding pharmacies can resume manufacturing more than half a dozen peptides that were barred in 2023. The ban covered 14...
One Health System CIO's Vision for Harnessing AI with Cybersecurity
Catawba Valley Health System’s CIO Nadin Knippschild says the organization must harness AI to improve efficiency while simultaneously strengthening cybersecurity as it moves more services to the cloud. She notes that nearly 37% of U.S. hospitals operate at a loss...
California Regional Hospital Taps Chief Nurse
PIH Health Whittier has promoted Lydia Arroyo, MSN, RN, to chief nursing officer. Arroyo joined the system in 2022 as senior director of maternal‑child health services and most recently served as vice president of nursing operations. In her new role...
Booster Speed-Processing Training Cuts Dementia Risk 25%
This one type of cognitive training might delay dementia.🧠🧠 In the ACTIVE randomized controlled trial, older adults were assigned to memory, reasoning, or speed training — then they were followed for 20 years. Standard memory and reasoning training didn't reduce dementia risk....
Discover Cutting‑Edge Stem Cell Advances at BEYOND 2026
The best place to learn about the latest stem cell research is at BEYOND, Austin, TX, May 27-29, 2026. Learn all the new ways stem cell research is growing and becoming more available from @stemcellchristian at the BEYOND Biohacking Conference. https://t.co/e04Xnfyjwa
More Insurance Claims Denials Are Being Overturned upon Appeal, Study Finds
A new JAMA study of roughly 51,000 New York claims shows denial overturn rates climbing from 38% in 2019 to nearly 53% in 2025. Overturn percentages differ sharply by service type—more than 78% for home‑health claims and just over 50% for...
Speedy Fixes: Removing Customer Roadblocks Drives Success
The CEO of UnitedHealthcare on Fixing What Frustrates Customers Most https://t.co/WWzA25AjwY The best organizations know how to move fast and remove roadblocks when it matters the most. #customerunderstanding #customerexperience https://t.co/fAADxWax0B
Promolytics: Targeting Cancer‑Promoting Clones to Halt Progression
A new review on tumor promotion and the evolution of cancer with the concept of "promolytics" —drugs that could prevent potentially dangerous clones and/or their progression https://t.co/IFah5gi8ZK @Nature
WHO Says Vaccinations Saving Millions in Africa, but U.S Aid Cuts and Iran War Threaten Progress
WHO’s new continent‑wide analysis shows that vaccination programs have saved tens of millions of African lives, reaching over 500 million children since 2000 and averting about 4 million deaths each year. Milestones include the 2020 eradication of wild poliovirus, the near‑elimination of...
New Market Map Highlights Agentic AI in Ambulatory Sector
Market maps have become a real focus of ours as LLMs are getting company categorization so wrong. Our latest, in partnership with Confido Health & @RMFnyc1, focuses on agentic AI for the ambulatory market. What's being deployed now? Our focus...